Statements (19)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:biotechnology
|
gptkbp:acquiredBy |
gptkb:Alfasigma
|
gptkbp:acquisitionYear |
2015
|
gptkbp:country |
gptkb:Italy
|
gptkbp:focusesOn |
oncology
rare diseases metabolic diseases |
gptkbp:foundedIn |
1957
|
gptkbp:founder |
gptkb:Claudio_Cavazza
|
gptkbp:headquartersLocation |
gptkb:Pomezia,_Italy
|
https://www.w3.org/2000/01/rdf-schema#label |
Sigma-Tau Pharmaceuticals
|
gptkbp:industry |
pharmaceuticals
|
gptkbp:notableProduct |
gptkb:Carmustine
gptkb:Dacarbazine L-carnitine |
gptkbp:numberOfEmployees |
2500
|
gptkbp:website |
https://www.sigma-tau.it/
|
gptkbp:bfsParent |
gptkb:Abelcet
|
gptkbp:bfsLayer |
7
|